Viral hepatitis among people who inject drugs

Auditorium IV
In programme
Thursday, 24 October, 2024 - 16:50 to 18:20
View presentations

About

This session will cover strategies for addressing hepatitis C and B within high-risk populations in community and prisons.

Chair

Dore
Gregory
Head, Viral Hepatitis Clinical Research Program
Kirby Institute, UNSW
 Australia
Placeholder Image
Ward
Zoe
Research Fellow
University of Bristol
 United Kingdom

Type

Oral presentation session

Tracks

Hepatitis C, other infectious diseases, and drug-related harms

Keywords

Public health
Criminology
Risky behaviours
Europe
Quantitative methods
Hepatitis
Qualitative methods
Treatment
Prevention
Infectious diseases
Monitoring and evaluation
Health inequalities
Criminal justice/prisons

Presentations

Thursday, 24 October

16:50

Oral presentation

Epidemiology of injecting drug use and injection related harms among people who are incarcerated

16:50 to 18:20
Auditorium IV
Louisa Degenhardt

Oral presentation

Context specific factors that impact on the optimal scale up of hepatitis C testing and treatment in the UK

16:50 to 18:20
Auditorium IV
Peter McCulloch

Oral presentation

The development of a toolkit to support the elimination of viral hepatitis B and C in prisons

16:50 to 18:20
Auditorium IV
Erika Duffell

Oral presentation

Towards elimination of hepatitis C in Oslo: cross-sectional prevalence studies in 2018, 2021, 2022 and 2023

16:50 to 18:20
Auditorium IV
Eirik Opheim
View the programme